http://www.physorg.com/health-news/cancer/ en-us PhysOrg.com provides the latest news on cancer, health, medicines, cancer treatments, cancer research, cancer studies and types of cancer. The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. http://www.physorg.com/news177076257.html Medicine & Health - Cancer Tue, 10 Nov 2009 12:30:02 EST news177076257 New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer. These findings are being presented this week at the North Central Section of the American Urological Association in Scottsdale, Ariz. http://www.physorg.com/news177076035.html Medicine & Health - Cancer Tue, 10 Nov 2009 12:00:01 EST news177076035 Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity. http://www.physorg.com/news177059142.html Medicine & Health - Cancer Tue, 10 Nov 2009 08:10:02 EST news177059142 Overall survival (OS) may be a reasonable primary endpoint when the median survival postprogession (SSP) is less than 6 months, but it is too high a hurdle when SPP is longer than 12 months, according to a new study published online November 9 in the Journal of the National Cancer Institute. http://www.physorg.com/news177059223.html Medicine & Health - Cancer Tue, 10 Nov 2009 07:40:01 EST news177059223 Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center. http://www.physorg.com/news177008484.html Medicine & Health - Cancer Mon, 09 Nov 2009 17:50:05 EST news177008484 Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. http://www.physorg.com/news177008338.html Medicine & Health - Cancer Mon, 09 Nov 2009 17:10:02 EST news177008338 For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news -treatments that enable survival often cause infertility. http://www.physorg.com/news176997811.html Medicine & Health - Cancer Mon, 09 Nov 2009 14:20:11 EST news176997811 St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old. http://www.physorg.com/news176997034.html Medicine & Health - Cancer Mon, 09 Nov 2009 13:52:05 EST news176997034 (PhysOrg.com) --A University of Arkansas researcher will study potential cancer-causing mutants of a protein involved in cell growth regulation, thanks to a supplemental grant from the National Institutes of Health. http://www.physorg.com/news176978222.html Medicine & Health - Cancer Mon, 09 Nov 2009 08:37:31 EST news176978222 A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. http://www.physorg.com/news176963764.html Medicine & Health - Cancer Mon, 09 Nov 2009 05:40:01 EST news176963764 The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. http://www.physorg.com/news176963676.html Medicine & Health - Cancer Mon, 09 Nov 2009 04:50:04 EST news176963676 Obesity causes more than 100,000 incidents of cancer in the US every year, the American Institute for Cancer Research said in estimates published Friday. http://www.physorg.com/news176749877.html Medicine & Health - Cancer Fri, 06 Nov 2009 17:30:01 EST news176749877 A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting. http://www.physorg.com/news176740788.html Medicine & Health - Cancer Fri, 06 Nov 2009 15:00:01 EST news176740788 Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. http://www.physorg.com/news176738875.html Medicine & Health - Cancer Fri, 06 Nov 2009 14:20:02 EST news176738875 People living in volcanic areas may be at a higher risk for thyroid cancer, according to a new study published online November 5 in the Journal of the National Cancer Institute. http://www.physorg.com/news176662195.html Medicine & Health - Cancer Thu, 05 Nov 2009 17:30:02 EST news176662195 The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. Thyroid is the official journal of the American Thyroid Association (ATA). http://www.physorg.com/news176652661.html Medicine & Health - Cancer Thu, 05 Nov 2009 16:20:01 EST news176652661 Since her teens, Jennifer Jablon had watched family members deal with breast cancer during their 40s, 50s, and 60s. She wondered whether it would be her fate too. http://www.physorg.com/news176652790.html Medicine & Health - Cancer Thu, 05 Nov 2009 15:20:01 EST news176652790 A new study by a team of researchers led by Crislyn D'Souza-Schorey, associate professor of biological sciences at the University of Notre Dame, sheds light on the molecular basis by which tumor cells modulate their surroundings to favor cancer progression. http://www.physorg.com/news176649486.html Medicine & Health - Cancer Thu, 05 Nov 2009 13:40:04 EST news176649486 For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options. http://www.physorg.com/news176644890.html Medicine & Health - Cancer Thu, 05 Nov 2009 12:30:01 EST news176644890 (PhysOrg.com) -- Most biopsies following mammograms reveal benign abnormalities, not cancer. But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin. http://www.physorg.com/news176644091.html Medicine & Health - Cancer Thu, 05 Nov 2009 12:10:02 EST news176644091 The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection. http://www.physorg.com/news176644002.html Medicine & Health - Cancer Thu, 05 Nov 2009 11:47:29 EST news176644002 (PhysOrg.com) -- A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer. The study drug, Bortezomib, was found to be effective against bone cancer in human cancer cell studies and in mice. While key experiments were in animals, the cancer studied closely resembled the human form and the drug has already been proven to be safe in human patients. http://www.physorg.com/news176642786.html Medicine & Health - Cancer Thu, 05 Nov 2009 11:35:59 EST news176642786 The ultimate goal in cancer research, a treatment that kills cancer cells whilst leaving healthy cells untouched, is brought nearer by the success of a new therapeutic approach. The potential therapy, published in BioMed Central's open access journal Breast Cancer Research, targets proliferation of cancer, but not normal, cells. http://www.physorg.com/news176623112.html Medicine & Health - Cancer Thu, 05 Nov 2009 07:30:02 EST news176623112 Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center. http://www.physorg.com/news176622813.html Medicine & Health - Cancer Thu, 05 Nov 2009 05:53:59 EST news176622813 Researchers at Fox Chase Cancer Center found that radiation treatment for women who had a lumpectomy for early-stage breast cancer can be safely reduced to four weeks, instead of the usual six to seven weeks, by delivering a higher daily dose--greatly reducing the length of treatment time. The five-year results of the phase II study will be presented today at the annual meeting of the American Society for Radiation Oncology. http://www.physorg.com/news176567679.html Medicine & Health - Cancer Wed, 04 Nov 2009 16:10:02 EST news176567679 Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. http://www.physorg.com/news176571296.html Medicine & Health - Cancer Wed, 04 Nov 2009 16:10:02 EST news176571296 A patient's socioeconomic status (income, martial status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry Ford Hospital in Detroit. http://www.physorg.com/news176567538.html Medicine & Health - Cancer Wed, 04 Nov 2009 15:00:01 EST news176567538 What do patients want from their radiation oncologists? The most significant preference is that more than one-third of female cancer patients (37 percent) prefer to have their hands held by their radiation oncologists during important office visits, compared to 12 percent of men, according to a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). http://www.physorg.com/news176565544.html Medicine & Health - Cancer Wed, 04 Nov 2009 14:10:01 EST news176565544 Designers of anti-cancer drugs are aiming their arrows at mysterious chunks of the genetic material DNA that may play a key role in preventing the growth and spread of cancer cells, according to an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine. http://www.physorg.com/news176559486.html Medicine & Health - Cancer Wed, 04 Nov 2009 12:30:03 EST news176559486 Patients with early stage, non-small cell lung cancer who are not able to undergo surgery, now have a highly effective treatment option. Physicians say that option, radical stereotactic radiosurgery performed with CyberKnife, leads to a 100 percent overall survival after three years in patients with good lung function before treatment. These are the results of a study presented today at the annual CHEST meeting in San Diego. The study is a semifinalist for an Alfred Soffer Research Award, selected for "outstanding original scientific research." http://www.physorg.com/news176524970.html Medicine & Health - Cancer Wed, 04 Nov 2009 03:50:13 EST news176524970